CYPH
NASDAQ · Biotechnology
Cypherpunk Technologies Inc
$0.64
0.00 (-0.62%)
Open$0.65
Previous Close$0.65
Day High$0.66
Day Low$0.62
52W High$3.70
52W Low$0.23
Volume—
Avg Volume1.35M
Market Cap68.49M
P/E Ratio—
EPS$-0.69
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+5,912.4% upside
Current
$0.64
$0.64
Target
$38.72
$38.72
$25.17
$38.72 avg
$55.57
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 17.60M | 17.28M | 16.86M |
| Net Income | 2.07M | 2.55M | 2.09M |
| Profit Margin | 11.8% | 14.8% | 12.4% |
| EBITDA | 4.18M | 3.81M | 3.82M |
| Free Cash Flow | 1.52M | 982.4K | 1.03M |
| Rev Growth | +11.2% | +9.6% | +9.9% |
| Debt/Equity | 0.55 | 0.54 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |